1. Home
  2. MESO vs FOXF Comparison

MESO vs FOXF Comparison

Compare MESO & FOXF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MESO
  • FOXF
  • Stock Information
  • Founded
  • MESO 2004
  • FOXF 2007
  • Country
  • MESO Australia
  • FOXF United States
  • Employees
  • MESO N/A
  • FOXF N/A
  • Industry
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • FOXF Motor Vehicles
  • Sector
  • MESO Health Care
  • FOXF Consumer Discretionary
  • Exchange
  • MESO Nasdaq
  • FOXF Nasdaq
  • Market Cap
  • MESO 1.3B
  • FOXF 1.2B
  • IPO Year
  • MESO N/A
  • FOXF N/A
  • Fundamental
  • Price
  • MESO $14.82
  • FOXF $27.25
  • Analyst Decision
  • MESO Buy
  • FOXF Buy
  • Analyst Count
  • MESO 3
  • FOXF 7
  • Target Price
  • MESO $18.00
  • FOXF $34.86
  • AVG Volume (30 Days)
  • MESO 230.7K
  • FOXF 397.4K
  • Earning Date
  • MESO 08-28-2025
  • FOXF 10-30-2025
  • Dividend Yield
  • MESO N/A
  • FOXF N/A
  • EPS Growth
  • MESO N/A
  • FOXF N/A
  • EPS
  • MESO N/A
  • FOXF N/A
  • Revenue
  • MESO $17,198,000.00
  • FOXF $1,441,852,000.00
  • Revenue This Year
  • MESO $293.59
  • FOXF $8.61
  • Revenue Next Year
  • MESO $218.64
  • FOXF $6.08
  • P/E Ratio
  • MESO N/A
  • FOXF N/A
  • Revenue Growth
  • MESO 191.39
  • FOXF 7.16
  • 52 Week Low
  • MESO $6.00
  • FOXF $17.95
  • 52 Week High
  • MESO $22.00
  • FOXF $44.27
  • Technical
  • Relative Strength Index (RSI)
  • MESO 50.33
  • FOXF 41.68
  • Support Level
  • MESO $12.66
  • FOXF $27.30
  • Resistance Level
  • MESO $15.67
  • FOXF $28.98
  • Average True Range (ATR)
  • MESO 0.45
  • FOXF 0.99
  • MACD
  • MESO -0.00
  • FOXF -0.18
  • Stochastic Oscillator
  • MESO 59.83
  • FOXF 0.90

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

About FOXF Fox Factory Holding Corp.

Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.

Share on Social Networks: